US Patent 8940316 Osmotic delivery comprising an insulinotropic peptide and uses thereof
Patent 8940316 was granted and assigned to Intarcia Therapeutics, Inc. on January, 2015 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8940316 Osmotic delivery comprising an insulinotropic peptide and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.